Key Technological
Our key technological advancements encompass N/C terminal modification, PEG modification, fluorescence labeling (including FITC, FAM, TAMRA, CY3, etc.), and biotin labeling. We also excel in producing multiple antigenic peptides (MAP) and cyclic peptides, which may include intramolecular or intermolecular disulfide/selenium bonds or stapled peptides.